147 Views

Goals of Treatment and Updates on Myeloproliferative Neoplasms

Sunday, November 6, 2022

Location: On-Demand

CE: .75 credit/contact hour

Speaker(s)

Identify the signaling pathways involved in non BCR-ABL myeloproliferative neoplasms (MPNs)
Distinguish between the three main MPN subtypes: Essential thrombocythemia, polycythemia vera, and myelofibrosis
Assess risk for each disease subtype
Develop treatment plans and associated goals with patients